Prasugrel Hydrochloride Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports
Global Prasugrel Hydrochloride MarketPrasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine. Similar to clopidogrel, prasugrel is a prodrug that requires enzymatic transformation in the liver to its active metabolite, R-138727. R-138727 irreversibly binds to P2Y12 type ADP receptors on platelets thus preventing activation of the GPIIb/IIIa receptor complex. As a result, inhibition of ADP-mediated platelet activation and aggregation occurs. Prasugrel was developed by Daiichi Sankyo Co. and is currently marketed in the United States and Canada in cooperation with Eli Lilly and Company for acute coronary syndromes planned for percutaneous coronary intervention (PCI). FDA approved in 2009.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-9O8387/Global_Prasugrel_Hydrochloride_Market_Insights_Forecast_to_2028
The global Prasugrel Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Prasugrel Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Prasugrel Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Prasugrel Hydrochloride include Daiichi Sankyo, Amneal Pharmaceuticals, Apotex, Ube, Ascend Laboratories, Liberty Pharmaceuticals and Panacea Biotec, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prasugrel Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prasugrel Hydrochloride.
The Prasugrel Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prasugrel Hydrochloride market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prasugrel Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-9O8387/Global_Prasugrel_Hydrochloride_Market_Insights_Forecast_to_2028
Key Segmentations
By Company
• Daiichi Sankyo
• Amneal Pharmaceuticals
• Apotex
• Ube
• Ascend Laboratories
• Liberty Pharmaceuticals
• Panacea Biotec
Segment by Type
• 5mg
• 10mg
Segment by Application
• Hospital
• Drugs Store
View full report
https://reports.valuates.com/market-reports/QYRE-Auto-9O8387/global-prasugrel-hydrochloride
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prasugrel Hydrochloride Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports here
News-ID: 3361120 • Views: …
More Releases from Valuates Reports
Global Motherboard Market Size: Size, Share, Growth, Analysis, Key Players, Reve …
Global Motherboard Market Size
The global Motherboard market was valued at US$ 13290 million in 2023 and is anticipated to reach US$ 14670 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-12Y12979/Global_Motherboard_Sales_Market_Report_2023
Report Scope
The Motherboard market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period…
Dual Energy X-ray Detector Market: Size, Share, Growth, Analysis, Key Players, R …
Dual Energy X-ray Detector Market
The global Dual Energy X-ray Detector market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-24G16240/Global_Dual_Energy_X_ray_Detector_Market_Research_Report_2024
Report Scope
The Dual Energy X-ray Detector market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and…
Triethylenetetramine (TETA) Market Size: Size, Share, Growth, Analysis, Key Play …
Triethylenetetramine (TETA) Market Size
The global Triethylenetetramine (TETA) market was valued at US$ 340.5 million in 2023 and is anticipated to reach US$ 482.3 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-25N9951/Global_Triethylenetetramine_TETA_Market_Insights_Forecast_to_2028
Report Scope
The Triethylenetetramine (TETA) market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the…
Thiamethoxam Market Size: Size, Share, Growth, Analysis, Key Players, Revenue, G …
Thiamethoxam Market Size
The global Thiamethoxam market was valued at US$ 2299.6 million in 2023 and is anticipated to reach US$ 4577.6 million by 2030, witnessing a CAGR of 10.2% during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-5X7815/China_Thiamethoxam_Market_Report_Forecast_2021_2027
Report Scope
The Thiamethoxam market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from…
More Releases for Prasugrel
Transient Ischemic Attack Market Size | COVID-19 Impact Analysis | Forecast to 2 …
The global transient ischemic attack market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period (2021-2027). The rising pervasiveness of cardiovascular diseases is one of the prime factors affecting and driving the market. According to the World Health Organisation (WHO) around 17.9 million people across the globe die due to cardiovascular diseases (CVD) every year. Moreover, Blood pressure is one of the important factors resulting…
Antiplatelet Drugs Market With Industry Overview, Supply Chain, Key Players, & A …
The in-depth research report on Antiplatelet Drugs Market added to its huge repository by DBMR provides imprehensive and all aspects of market research. The market insights of this market report helps with the successful launch of new product. The report efficiently gathers, analyzes and interprets information about a market, about a product or service to be offered for sale in that market. Potential customers for the product or service and their…
Prasugrel Hydrochloride Market 2020| Global Leading Players, Industry Updates, F …
Complete study of the global Prasugrel Hydrochloride market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Prasugrel Hydrochloride industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also…
Antiplatelet Drugs Market 2018 - 2026 | Develop Rapidly By Top Players Bristol-M …
Antiplatelet drugs are prescribed to individuals with a history of heart attacks and these drugs aid in reducing reoccurrence of heart attacks. Some of the antiplatelet medications include, aspirin, clopidogrel, prasugrel, and ticagrelor. Aspirin is recommended for all patients with Acute Coronary Syndrome (ACS), in the absence of hypersensitivity. It is prescribed along with one of the oral antiplatelet agents including Clopidogrel, Prasugrel, and Ticagrelor. Prasugrel is prescribed for patients…
Dual Antiplatelet Therapy Market Value Insights, Analysis and Segments 2018 to 2 …
Dual antiplatelet therapy is defined as the use of aspirin and P2Y12 receptor inhibitor to prevent blood clotting, and through a double mechanism, it prevents thrombotic complications. The dual antiplatelet therapy is often prescribed for patients who had a cardiac attack, had coronary artery bypass graft surgery (CABG), or were treated with stents in coronary arteries. Growing prevalence of cardiovascular disease on the coattails of changing lifestyles habits is expected…
Antiplatelet Drugs Medication: A Review of Pharmacology and Management in the Pe …
Antiplatelet drugs are prescribed to individuals with a history of heart attacks and these drugs aid in reducing reoccurrence of heart attacks. Some of the antiplatelet medications include, aspirin, clopidogrel, prasugrel, and ticagrelor. Aspirin is recommended for all patients with Acute Coronary Syndrome (ACS), in the absence of hypersensitivity. It is prescribed along with one of the oral antiplatelet agents including Clopidogrel, Prasugrel, and Ticagrelor. Prasugrel is prescribed for patients…